We are 4-cyanobenzylchloride CAS:874-86-2 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
CAS No: 874-86-2
Product Name: 4-cyanobenzylchloride
Density: 1.2±0.1 g/cm3
Boiling Point: 271.0±23.0 °C at 760 mmHg
Melting Point: 77 °C
Molecular Formula: C8H6ClN
Molecular Weight: 151.593
Flash Point: 120.2±17.6 °C
Exact Mass: 151.018875
Vapour Pressure: 0.0±0.6 mmHg at 25°C
Index of Refraction: 1.551
Appearance: White crystal
The p-cyanobenzyl chloride, also known as 4-cyanochlorobenzyl, is an important raw material for synthesizing the fluorescent whitening agent stilbene, and is also widely used as an intermediate for synthesizing fine chemicals, pharmaceutical, dyes and the like.
For the synthesis of m-trifluoromethylbenzene p-cyanoacetophenone, which is an important intermediate for cyanofluorfen.
For the synthesis of a strong hemostatic drug ammonia toluic acid.
Applicationd to prepare dicyano-1,4-styrene asymmetric fluorescent whitening agents.
An intermediate of the drug pyrimethamine.
Applicationd in the manufacture of p-chlorobenzyl alcohol, p-chlorobenzaldehyde, p-chlorophenylacetonitrile and the like.
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Related News: The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.5-Methoxy-2-mercaptobenzimidazole CAS:37052-78-1 The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.2-desoxi-2,2-difluoro-D-eritro-pentofuranosa-3,5-dibenzoato-1-metanosulfonato CAS:122111-11-9 The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.13532-18-8 The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.